Cargando…
Radiomics Models Based on Magnetic Resonance Imaging for Prediction of the Response to Bortezomib-Based Therapy in Patients with Multiple Myeloma
PURPOSE: To identify significant radiomics features based on MRI and establish effective models for predicting the response to bortezomib-based regimens. MATERIALS AND METHODS: In total, 95 MM patients treated with bortezomib-based therapy were enrolled, including 77 with bortezomib, cyclophosphamid...
Autores principales: | Li, Yang, Yin, Ping, Liu, Yang, Hao, Chuanxi, Chen, Lei, Sun, Chao, Wang, Sicong, Hong, Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467708/ https://www.ncbi.nlm.nih.gov/pubmed/36105939 http://dx.doi.org/10.1155/2022/6911246 |
Ejemplares similares
-
MRI-Based Bone Marrow Radiomics Nomogram for Prediction of Overall Survival in Patients With Multiple Myeloma
por: Li, Yang, et al.
Publicado: (2021) -
Bortezomib in the management of multiple myeloma
por: Laubach, Jacob P, et al.
Publicado: (2009) -
The Choice of Regimens Based on Bortezomib for Patients with Newly Diagnosed Multiple Myeloma
por: He, Jingsong, et al.
Publicado: (2014) -
Bortezomib (Velcade™) in the Treatment of Multiple Myeloma
por: Field-Smith, Antonia, et al.
Publicado: (2006) -
Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapy
por: Yang, Fei, et al.
Publicado: (2018)